DIXON WENDY L - Insider Non-Derivative Transactions at Black Diamond Therapeutics, Inc. (BDTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 15, 2024, DIXON WENDY L's relationship to Black Diamond Therapeutics, Inc. (BDTX) is Director, and currently has 38,054 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BDTX insiders.
Data Source: SEC.
DIXON WENDY L - Insider Non-Derivative Transactions of BDTX Common Stock
DIXON WENDY L - Insider Non-Derivative Transactions at BDTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 16, 2024 | Acquisition -- (Common Stock) | 3253 | 4.54 | 38054 |
| Dec 16, 2023 | Acquisition -- (Common Stock) | 4043 | 2.73 | 34801 |
| Sep 16, 2023 | Acquisition -- (Common Stock) | 2986 | 3.6 | 30758 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 5119 | 2.1 | 27772 |
| Mar 17, 2023 | Acquisition -- (Common Stock) | 6437 | 1.67 | 22653 |